Endogenous opioids have been implicated in mediating (placebo) analgesia, in reward processes and in the regulation of socially relevant emotions. To explore their potential contribution to higher cognitive functions, we used a novel task with tachistoscopically (150ms) presented pairs of meaningless figures. Healthy right-handed men judged the similarities and dissimilarities between the two figures on a visual analogue scale (VAS) in two separate runs. In a double-blind, between-subject design, participants were administered either 0.2 mg/kg naloxone intravenously or placebo 10 minutes prior to the task. VAS judgments and response latencies were measured. There was a significant interaction between substance group and type of judgment; the magnitude of similarity judgments was lower in the naloxone than in the placebo group, while dissimilarity judgments remained uninfluenced by the treatment. Reaction latencies and mood scores, assessed before and after substance administration, did not differ between the two groups, indicating that the findings do not rely on altered motor performance or motivation. We infer that naloxone decreased the "similarity criterion" in comparative judgments, indicating its modulatory effect on visual cognition. The task introduced here could be used for the implicit study and quantification of subtle affective-cognitive processes beyond the level of mere questionnaire data.
Introduction
Endogenous opioid systems have mainly been implicated in affective processes such as the response to reward (Smith and Berridge, 2007) , the modulation of endocrine functions (e.g. Drolet et al., 2001) , the regulation of affect (e.g. Zubieta et al., 2003) , pleasure-related analgesia (Leknes and Tracey, 2008, Kut et al., 2011) and the mediation of (placebo) analgesia (e.g. Petrovic et al., 2002) . Moreover, several lines of evidence indicate that the neurocircuitry and neurochemistry of physical pain overlap with those of more abstract, complex cognitive-affective experiences such as social emotions (Macdonald and Leary, 2005, Stein et al., 2007) , in particular social attachment (Herman and Panksepp, 1978 , Panksepp et al., 1980 , Moles et al., 2004 , Barr et al., 2008 . In a recent neuroimaging study with healthy subjects, Eisenberger et al. (2003) showed that neural networks activated during distress caused by social exclusion are also activated during physical pain and that pain experience can be reduced by visual stimuli signalling attachment (Eisenberger et al., 2011) . In line with these findings of "social distance regulation" is the general explanation for the feeling of physical pain that accompanies emotional loss (Panksepp, 2003) , whether it be the loss of a loved one (Zubieta et al., 2003) , rejection by one's social group (Eisenberger et al., 2003 , Eisenberger et al., 2006 , or the distress experienced by young animals when being separated from their parents (Panksepp, 1998) .
In healthy humans, opioid agonists have been implicated in feelings of emotional relatedness or social emotions and in mood-elevating effects (Schaffer et al., 2007 , Gospic et al., 2008 , Koepp et al., 2009 . By contrast, the mu-opioid antagonist naloxone has been shown to influence endocrine functions (Drolet et al., 2001 ) and occasionally reported to induce dysphoric mood states at doses over 0.25 mg/kg (Mendelson et al., 1978 , Grevert et al., 1983 , Martin del Campo et al., 1992 , Martin del Campo et al., 1994 . However, it remains Naloxone and Cognitive Relatedness 4 to be established in how far discrepancies in study findings may be a consequence of the lack of a reliable measure and methodological difficulties.
Most surprisingly, beside reported opioidergically modulated mood effects, only a few studies have so far investigated influences on other higher brain functions such as naloxonedependent alterations in attention (Buchsbaum et al., 1982 , Arnsten et al., 1983 , Arnsten et al., 1984 and memory (Cohen et al., 1983 , Kamboj et al., 2005 , Friswell et al., 2008 . More recently, Biederman and colleagues suggested that mu-opioids are involved in perceptual pleasure Vessel, 2006, Yue et al., 2007) . However, their influence on cognitive judgmental processes is largely unexplored. Endogenous opioids' influence on cognitive functioning is thus of central importance for both, basic and clinical research (Ersek et al., 2004 for a clinical review).
From a phenomenological perspective, a cognitive equivalent to emotional feelings of relatedness, or more broadly "social emotions", could be conceptualized as "coherence perception" or distance regulation. Judgments of similarity/dissimilarity are an important, often neglected, component in a variety of cognitive processes, including object recognition (Barenholtz and Tarr, 2008) , semantic and perceptual categorization (Pettigrew, 1958) , esthetics (Wertheimer, 1923 (Wertheimer, /1958 , and analogic reasoning (Novick, 1988) and belief formation (Gianotti et al., 2001) . Spotting similarity has also been proposed to be a fundamental aspect of various cognitive processes such as making inferences, knowledge generalization, and knowledge transfer (e.g. Gentner et al., 1993) .
Although the question of how people judge similarity and dissimilarity is clearly of critical importance in social cognition (e.g. Mitchell et al., 2006) and in cognitive psychology, little is known about its neurochemical underpinnings and whether it can be considered a Naloxone and Cognitive Relatedness 5 distinct cognitive system. We here introduce a novel judgment task assessing "cognitive relatedness" or formal visual coherence/contrast perception. In a visual perceptual task stimulating cognitive judgments of visual similarity and dissimilarity we investigated whether a mu-opioid receptor antagonist (naloxone) could modify healthy subjects' judgments of similarity/dissimilarity. We predicted decreased similarity (coherence perception) and increased dissimilarity (contrast perception) judgments in participants receiving a naloxone injection. Moreover, we hypothesized a dissociation of similarity and dissimilarity, i.e. we assumed that they would not represent two endpoints on a bipolar scale, but instead provide two independent, context-related frames of reference.
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Material and Methods

Subjects:
Volunteers were 21 advertisement-recruited healthy right-handed men (mean handedness score (Chapman and Chapman, 1987) = 13.9, SD = 1.6, range = 13 -19), 19 -44 years of age (mean = 26.7, SD = 7.4). All subjects gave written informed consent to the experimental procedures, which had been approved by the local ethics committee.
Health status of the participants was assessed with a detailed questionnaire (Campbell, 2000) . All subjects confirmed the absence of any relevant acute or chronic disease (hypertension, heart disease, renal disease, liver disease, mental illness, or seizure disorder), a history of neurological disorder, a mental illness or mental impairment. The MDBF questionnaire is a short, multidimensional, self-evaluative questionnaire that describes the current mood state of an individual on three dimensions "good vs. bad mood," "wakefulness vs. sleepiness," and "calmness vs. restlessness."
Judgment tasks
Similarity and dissimilarity judgment tasks. Eighteen different stimulus pairs consisting of two horizontally placed meaningless geometric figures were tachistoscopically presented (exposure time = 150 ms). One figure of a pair was presented to the left, and the other to the right side of a central fixation cross (horizontal eccentricity = 1.5° to 3.0° of visual angle). The single pairs were constructed respecting the Gestalt laws of proximity, good continuation, closure, similarity, and figure/ground properties. Each stimulus pair was also presented in a vertically mirrored version. There were two counterbalanced runs consisting of 36 trials; in one subjects had to indicate similarity (SJ: similarity judgment) and in the other dissimilarity (DJ: dissimilarity judgment) with a computer mouse in their right hand on a 9-inch bipolar visual analogue scale (VAS) presented against a light gray background (Figure 1 ). All objects (object size: within 2.8 x 2.8 cm, lines thickness: 2 point) were printed in black and presented on a computer screen (gray background). Sample stimuli are illustrated in Fig.1 .
Stimulus pairs were identical in both the SJ and DJ runs, but presented in a different, pseudorandomized order.
Participants were asked to rest their head on a chin rest, and to fixate the cross in the centre of the screen during stimulus exposure. They were instructed to respond as quickly and intuitively as possible and were told that their preference ratings on similarity/dissimilarity judgments were highly subjective and that there were neither false nor correct judgments. 
Double-blind procedure
Naloxone administration. The study had a randomized, double-blind, placebo-controlled, between-subject design. Naloxone hydrochloride (n = 10, 0.2 mg / kg bodyweight, concentration 1mg/ml, pharmacy of the Kanton Zürich) or the equivalent volume of NaCl (n = 9, 0.9 %, pharmacy of the Kanton Zürich), respectively was administered. Similar naloxone dosages have been previously shown to completely antagonize endogenous opioidmediated analgesia in healthy volunteers (Amanzio and Benedetti, 1999) . To prevent high stress levels during the experiment, a nurse laid an intravenous catheter at the inner elbow of the non-dominant arm 10 minutes prior to task administration. The entire testing was supervised by a medical doctor. All participants had been asked to refrain from any alcohol, caffeine-or taurin-containing beverage for at least 12 hours before the start of the experiment and confirmed their compliance in the debriefing. At the end of behavioral testing, participants were asked (by questionnaire) which substance they thought they had received.
Data analysis
Two separate two-way ANOVAs with substance group (naloxone vs. placebo) as betweensubject factors, and run (similarity vs. dissimilarity rating) as repeated measures were calculated for the position on the VAS (VAS-magnitude in percent) and reaction latencies. Outlier detection was performed by the Grubb-Test. To test for a naloxone influence on psychometrically assessed mood, a three-way repeated measure ANOVA was computed comprising the between-subject factor substance (naloxone vs. placebo), and the withinsubject factors time (beginning vs. end of the experiment) and mood dimension (valence, wakefulness, calmness).
Two subjects did not adhere to the judgment task instruction and constantly pressed the keyboard instead of using the mouse to indicate the degree of similarity or dissimilarity on the VAS. Valid data were thus available from 19 participants.
Results
Handedness, Age and Blinding
Participants in the naloxone and placebo group did not differ from one another in age (t(17) = -1.72, p = .11) and the strength of right-handedness (t(17) = 1.78, p = .112).
There was no association between what substance participants believed they had received (drug or placebo) and what they had actually received, which suggests that blinding was effective (χ2 = 0.259 p = .611): eighty-four percent of the study participants believed they had received saline. Two participants who thought they had received naloxone were in the placebo group and one participant under the influence of naloxone correctly detected the substance. .945). Moreover, while in the placebo group VAS magnitudes were higher for similarity than for dissimilarity judgments (p = .036), VAS magnitudes for similarity and dissimilarity in the naloxone group were not significant different from one another (p = .085).
Questionnaires
---------------------------------INSERT FIGURE 2 ABOUT HERE--------------------------------------
Reaction latencies: there were no significant main effects or interactions (all F-values ≤
1.716, corresponding p-values ≥ .208).
Discussion
Healthy participants were administered a novel perceptual cognitive judgment task assessing visual similarity and dissimilarity. In a double-blind, naloxone, placebo-controlled between-subject design we aimed to investigate a role of endogenous opioids in "cognitive relatedness".
We focused on the hypothesis that a cognitive equivalent to social distance regulation might be conceptualized as "cognitive relatedness", and could be dependent on mu-opioid receptor activity.
In short, the results both support and contradict our original hypothesis. The kind of coherence perception interacted with naloxone administration. More specifically, the VAS magnitude of similarity judgments but not dissimilarity judgments of visual presented object pairs were more moderate (e.g. a shift towards low similarity) for participants in the naloxone than in the placebo group. Reaction latencies did not differ in the two groups. In addition, psychometrically assessed mood did not differ between the placebo and naloxone group. Therefore, the effects of altered VAS magnitudes are unlikely to simply reflect naloxoneinduced altered motor performance and/or motivation and thus did not confound the operationalization of the cognitive judgments.
High similarity was perceived differently from low dissimilarity but only in the placebo, but not in the naloxone group. The VAS magnitude of similarity was more pronounced than that of dissimilarity.
We thus infer that the opioid antagonist naloxone decreased the "analogy criterion" in visual cognitive-affective judgments, but only when framed for similarity, but not for dissimilarity. This finding demonstrates a modulatory effect of naloxone on judgments of cognitive relatedness and suggests that some aspects of formal cognition, i.e. the readiness 12 to judge something as similar and simultaneously as dissimilar might be dependent on muopioid receptor activity.
Clearly, although we did not find psychometrically assessed mood differences between the placebo and naloxone group, further research needs to disentangle whether the altered cognitive strategies in similarity judgments are due to naloxone-induced changes in the affective system (i.e. a mildly detached or dysphoric mood) or are the result of a specific, opioid-associated cognitive focusing on formal stimulus properties perceived to be related to one another. This could be done through use of more elaborated and combined formally complex and affectively loaded visual stimuli and by showing an accentuation of similarity judgments under the influence of opioidergic agonists. Most insightful would be a replication of our approach using positron-emission tomography with [(11)C]carfentanil (Zubieta et al., 2003) to measure possible cortical regional mu-opioid receptor availability in vivo. Indeed, a high density of mu-opioid receptors in the brains of macaque monkeys (Lewis et al., 1981, Wise and Herkenham, 1982) and similar findings in human subjects (Quirion and Pilapil, 1991) , has been found to be distributed along a gradient that increases in density along the ventral visual pathway and in association areas such as the parahippocampal cortex.
One may dare to surmise that distinct biological systems are specifically involved in the neuronal generation of coherence perception. This type of perception, if not a human equivalent of "social emotions" in animals (Herman and Panksepp, 1978 , Panksepp et al., 1980 , Panksepp, 2003 , may arguably be at the heart of spotting similarities in objects, minds and intentions that surround an individual. Under this broad perspective, one further effect uncovered in the present study deserves to be mentioned. Judging two stimuli as highly similar in the similarity judgment run was no indicator of how dissimilar those same stimuli would be perceived in the dissimilarity judgment run. That is, the perception of relatedness, or "coherence perception", is by no means a homogenous perceptual-cognitive 13 act. Rather, emphasis on resemblance and unity may principally differ from a focus on distinctive features of scene or social interaction.
From a methodological point of view, classical self-report measures for affective states have cast doubt on the reliability of these measurements (e.g. Clark and Schober, 1992, Tourangeau et al., 2000) . Our novel task could thus provide a non-verbal, indirect, sensitive cognitive measure for the implicit study and quantification of subtle affectivecognitive (51) [51] [51][51] processes such as pain judgment and evaluative reasoning beyond the level of mere questionnaire data. To conclude, whether the glass is judged half-full or half-empty may (see Figure 3 for an illustrative ambigram) depend on the rater's balancing of positive and negative affect. The former tends to promote cognitive, "relational processes", whereas the latter may inhibit relational processing and narrow down the focus on stimulusspecific processing (Clore and Palmer, 2008 ).
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The authors declare that they have no competing financial interests. consisting of two horizontally placed meaningless geometric objects was bilaterally exposed for 150 ms (balanced for object side order). Subsequently, the degree of similarity or dissimilarity by clicking on the computerized VAS had to be indicated. In order to control the baseline mouse position, participants had to click on the fixation cross in the middle of the screen after each judgment (which elicited the next trial). Participants were instructed to respond as quickly and as intuitively as possible and to fixate their gaze on a cross in the center of the screen. 
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